Dipeptidyl peptidase-4(DPP-4)inhibitors can effectively improve blood glucose control in individuals with T2DM and notably decrease glucose variability when compared to alternative oral medications for diabetes (12, 13). The gene discussed is DPP4; the disease is type 2 diabetes mellitus.